Evidence map›Paper›PMID 31003998›Full record

ArticleBlood2019

With equal access, African American patients have superior survival compared to white patients with multiple myeloma: a VA study.

Nathanael R Fillmore, Sarvari V Yellapragada, Chizoba Ifeorah, Ansh Mehta, Diana Cirstea, Paul S White, Gustavo Rivero, Andrew Zimolzak, Saiju Pyarajan, Nhan Do and 2 more

Abstract readLetter
In one paragraph

Article in Blood, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Actionable Steps to Address Disparities in Healthcare Among US Patients With Multiple Myeloma: A Patient Perspective.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nathanael R FillmoreVA Boston Healthcare System, Boston, MA.ORCID 0000-0002-8058-3423
Sarvari V YellapragadaMichael E. DeBakey VA Medical Center, Houston, TX.
Chizoba IfeorahMichael E. DeBakey VA Medical Center, Houston, TX.
Ansh MehtaUniversity of South Alabama Hospitals, Mobile, AL; and.
Diana CirsteaVA Boston Healthcare System, Boston, MA.
Paul S WhiteVA Boston Healthcare System, Boston, MA.ORCID 0000-0001-8345-0573
Gustavo RiveroMichael E. DeBakey VA Medical Center, Houston, TX.
Andrew ZimolzakVA Boston Healthcare System, Boston, MA.
Saiju PyarajanVA Boston Healthcare System, Boston, MA.
Nhan DoVA Boston Healthcare System, Boston, MA.
Mary BrophyVA Boston Healthcare System, Boston, MA.
Nikhil C MunshiVA Boston Healthcare System, Boston, MA.

Funding

Targeting Genomic Instability and Evolution in MyelomaP01CA155258 · NCI · DANA-FARBER CANCER INST · PI RICHARD YOUNG · 2011 to 2026
$32.5M
MOLECULAR MANIPULATION TO ENHANCE ANTI-MYELOMA RESPONSEI01BX001584 · VA · VA BOSTON HEALTH CARE SYSTEM · PI MUNSHI, NIKHIL C. · 2013 to 2025
–
BLRD VA I01 BX001584NCI NIH HHS P01 CA155258
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health Status DisparitiesAdultAgedAged, 80 and overBlack or African AmericanFemaleHealth Services AccessibilityHumansMaleMiddle AgedMultiple MyelomaUnited StatesUnited States Department of Veterans AffairsWhite People

Identifiers

PMID31003998
PMCPMC6566591

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.